-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618A.O1.6 618. Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis: Functional Genomics in Prognosis and Novel Therapies

Symposia: Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Fundamental Science, MDS, Lymphoid Leukemias, ALL, Translational Research, Assays, CHIP, Clinical Research, Bioinformatics, Genomics, Chronic Myeloid Malignancies, Hematopoiesis, Diversity, Equity, and Inclusion (DEI), Diseases, Immune mechanism, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Natural Killer (NK) Cell Therapies, Pathogenesis, Omics technologies
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Ing Soo Tiong, FRACP, FRCPA, MPhil, ARRAY(0xeb236a4) and Brent Ferrell Jr., MD, Vanderbilt University School of Medicine
Disclosures:
Tiong: Novartis: Speakers Bureau; Jazz: Honoraria; Pfizer: Speakers Bureau. Ferrell: Novartis: Research Funding.
4:00 PM

Masayuki Umeda, MD, PhD1, Nicole L Michmerhuizen, PhD2, Ryan Hiltenbrand2*, Juan M Barajas, PhD2, Bright Arthur2*, Michael P Walsh, PhD2*, Guangchun Song2*, Jing Ma, PhD2*, Tamara Westover2, Petri Pölönen, PhD2, Cristina Mecucci, MD, PhD3, Danika Di Giacomo, PhD4*, Franco Locatelli, MD5, Riccardo Masetti, MD, PhD6*, Salvatore Bertuccio, PhD7*, Martina Pigazzi, PhD8*, Ilaria Iacobucci, PhD9, Charles G. Mullighan, MBBS, MSc, MD2 and Jeffery M Klco, MD, PhD2

1Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
3Hematology, CREO, Centro Ricerche Emato-Oncologiche, University of Perugia, Perugia, Italy
4University of Perugia, Perugia, Italy
5IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy
6Pediatric Hematology-Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
7IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
8Department of Women's and Children's Health, Onco-hematology lab and clinic, University of Padova, Padova, Italy
9St. Jude Children's Research Hospital, Memphis, TN

4:15 PM

Leah Kravets, MS1, Mirca S. Saurty-Seerunghen, PhD2*, Divij Verma, PhD1, Ariel Fromowitz, MD3, Srabani Sahu, MS1*, Bradley Rockwell, MD4, Olivia Sakaguchi2*, Swathi Narayanagari, MS5*, Shanisha Gordon Mitchell1*, Milagros Carbajal1*, Srinivas Aluri, PhD1, Jingli Wang, PhD5*, Lindsay Lafave, PhD5*, Marina Konopleva6, Anna S. Nam, MD2 and Amit Verma, MD1

1Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY
2Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, New York, NY
5Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY
6Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Bronx, NY

4:30 PM

Bailee N. Kain, PhD1, Sidharth Sen, PhD2*, Deedra Nicolet, MS3*, Sierra N. Bennett, BS1*, David Bernardicius, BS1*, Yueh-Chiang Hu, PhD4,5*, Christopher Walker, PhD3*, Ann-Kathrin Eisfeld, MD3,6,7, Nathan Salomonis, PhD2,8* and H. Leighton Grimes, PhD1

1Division of Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH
2Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH
3The Ohio State University Comprehensive Cancer Center, Columbus, OH
4Transgenic Animal and Genome Editing Core, Cincinnati Children's Hospital, Cincinnati, OH
5Department of Pediatrics, University of Cincinnati, Cincinnati, OH
6The Ohio State University, Columbus, OH
7Alliance Statistics and Data Management Center, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

4:45 PM

Yu Liu1*, Wenbing Liu1*, Yihan Mei1*, Qing Rao2*, Runxia Gu, MD2*, Min Wang1*, Jianxiang Wang, MD1 and Shaowei Qiu, MD1*

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China

5:00 PM

Hanna Duàn, MSc1,2,3*, Emmi Jokinen1,4,5*, Hanna Lähteenmäki, MSc1,2,3*, Jay Klievink, M.Sc1,3,5*, Jonas Bouhlal, MSc, BSc1,3,6*, Essi Laajala, PhD1,2,3*, Jason Theodoropoulos, MSc1,3,6*, Heikki Kuusanmäki, PhD7,8,9*, Tanja Ruokoranta, MSc9*, Pauliina Rumm1,3*, Dean Anthony Lee, MD, PhD10, Esa Pitkänen, PhD6,9,11*, Tomi P Mäkelä, MD, PhD6,12*, Kimmo Porkka, MD, PhD1,4,13,14, Oscar E. Brück, MD, PhD15*, Olli Dufva, MD, PhD1,2,3* and Satu Mustjoki, MD, PhD1,4,14

1Translational Immunology Research Program, University of Helsinki, Helsinki, Finland
2iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
3Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
6ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
7Biotech Research & Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark
8Foundation for the Finnish Cancer Institute, Helsinki, Finland
9Institute for molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
10Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
11Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland
12HiLIFE-Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland
13Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
14ICAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
15Hematoscope Lab, Comprehensive Cancer Center & Center of Diagnostics, Helsinki University Hospital & University of Helsinki, Helsinki, Finland

5:15 PM

Li Li, MD, PhD1*, Muharrem Muftuoglu, MD1, Edward Ayoub, PhD1*, Aram Bidikian, MD2*, Prashant Menon, Ph.D3*, Jiangxing Lv1*, Mahesh Basyal, BSc1*, Andrea Bedoy1*, Anudishi Tyagi, PhD2*, Amanda Eckstrom, B.S.2*, Venkata Lokesh Battula, PhD4, Navin Varadarajan, PhD3*, Ghayas C. Issa, MD2 and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Houston, Houston, TX
4Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH